CLINICAL_TRIALS
trial_result
· 2025-11-13
Clinical Trial Update: Open-Label Extension of Voxelotor [Phase 3]
Summary
Open-label extension of voxelotor in sickle cell disease (Phase 3) has been terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 3 | Status: TERMINATED | Results posted: 2025-11-13